bpc-157 fda warning letter unapproved new drug The Peptide Craze FDA Sends Warning Letters to
Description
Maintains Potency: By inhibiting the growth of microorganisms, this method helps maintain the stability and effectiveness of the reconstituted peptides over an extended period

S., Pfaff, S

doi: 10.1016/j.pmedr.2025.102999 222

And after five half-lives, roughly 25 to 30 days, less than 3% of the original dose remains in circulation
Nothing here says TB-500 + BPC-157 treats, cures, or improves any condition
